Karel Helman - Dissemin

Language
Login

All papers authored by Karel Helman

This paper is made freely available by the publisher.

2021 Magdalena Klanova, Dmitry Kazantsev, Eva Pokorna, Tomas Zikmund

ORCID

, Jana Karolova

ORCID

, Matej Behounek

ORCID

, Nicol Renesova, Dana Sovilj, Cristina D. Kelemen, Karel Helman

ORCID

ORCID

, Ondrej Havranek, Ladislav Andera, Marek Trneny, Pavel Klener

ORCID

Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas

Download from aacrjournals.org

This paper was not found in any repository, but could be made available legally by the author.

2020 Ondřej Lidický, Pavel Klener, Daniela Machová, Petra Vočková, Eva Pokorná, Karel Helman

ORCID

, Cory Mavis, Olga Janoušková, Tomáš Etrych

ORCID

Overcoming resistance to rituximab in relapsed non-Hodgkin lymphomas by antibody-polymer drug conjugates actively targeted by anti-CD38 daratumumab

Upload

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

2019 Elizabeth A. Lemm, Beatriz Valle-Argos, Lindsay D. Smith, Johanna Richter

ORCID

, Yohannes Gebreselassie, Matthew J. Carter, Jana Karolova

ORCID

, Michael Svaton, Karel Helman

ORCID

, Nicola J. Weston-Bell

ORCID

, Laura Karydis, Chris T. Williamson, Georg Lenz, Jeremy Pettigrew, Curtis Harwig and 8 other authors

Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells

Upload

This paper was not found in any repository, but could be made available legally by the author.

Dana Prukova, Ladislav Andera, Zuzana Nahacka, Jana Karolova

ORCID

, Michael Svaton, Magdalena Klanova, Ondrej Havranek, Jan Soukup, Karla Svobodova, Zuzana Zemanova, Diana Tuskova, Eva Pokorna, Karel Helman

ORCID

, Kristina Forsterova, Mariana Pacheco-Blanco and 5 other authors

Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma

Upload

Missing publications? Search for publications with a matching author name.